Weld Capital Management’s Regenxbio RGNX Stock Holding History

Weld Capital Management’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-22,064	Closed	-$1.26M	–	904
2019 Q1	$1.26M	Buy	+22,064	New	+$1.09M	0.23%	150

Other funds holding RGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WS Management Jacksonville, Florida $1.13B AUM 53.44% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Weld Capital Management's RGNX Position: Q2 2019 in Review

Weld Capital Management sold out of Regenxbio (RGNX) in Q2 2019, closing a stake of 22,064 shares — an estimated $1.26M sold.

Weld Capital Management first reported a position in RGNX in Q1 2019 and held it in 1 quarter. The position peaked at $1.26M in Q1 2019. 186 funds tracked by Wall St. Rank hold RGNX as of Q2 2019.

Weld Capital Management reported no remaining Regenxbio position as of Q2 2019 after selling out during the quarter.
Weld Capital Management sold 22,064 Regenxbio shares in Q2 2019, an estimated $1.26M.
Weld Capital Management first reported a position in Regenxbio in Q1 2019 and held it in 1 quarter.
Weld Capital Management's Regenxbio position peaked at $1.26M in Q1 2019.
186 funds tracked by Wall St. Rank held Regenxbio as of Q2 2019.

Based on Weld Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.